Pharmaceutical

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)

Santen Pharmaceutical Co., Ltd.August 6, 20264

Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)

About this update from Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. (4536) Press Release View Attachment

View stock analysis, news, and events for Santen Pharmaceutical Co., Ltd.

More from Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical : New Drug Application Filing Accepted for Review in China for STN1012700 (Atropine Sulfate Ophthalmic Solution 0.0...

September 14, 2026

Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan

September 3, 2026

All Santen Pharmaceutical Co., Ltd. news →